Commerzbank Aktiengesellschaft Biomarin Pharmaceutical Inc Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$79.55 - $124.22 $269,594 - $420,981	-3,389 Closed	0 $0
Q1 2020 Oct 03, 2024	BUY	$71.37 - $96.85 $241,872 - $328,224	3,389 New	3,389 $286,000
Q1 2020 Apr 29, 2020	SELL	$71.37 - $96.85 $290,975 - $394,857	-4,077 Reduced 54.61%	3,389 $286,000
Q4 2019 Oct 03, 2024	BUY	$64.27 - $86.37 $479,839 - $644,838	7,466 New	7,466 $631,000
Q4 2019 Jan 17, 2020	BUY	$64.27 - $86.37 $15,489 - $20,815	241 Added 3.34%	7,466 $631,000
Q3 2019 Oct 03, 2024	BUY	$67.4 - $85.11 $486,965 - $614,919	7,225 New	7,225 $487,000
Q3 2019 Oct 17, 2019	BUY	$67.4 - $85.11 $131,362 - $165,879	1,949 Added 36.94%	7,225 $487,000
Q2 2019 Oct 03, 2024	BUY	$80.35 - $93.9 $423,926 - $495,416	5,276 New	5,276 $452,000
Q2 2019 Jul 23, 2019	BUY	$80.35 - $93.9 $47,085 - $55,025	586 Added 12.49%	5,276 $452,000
Q1 2019 Oct 03, 2024	BUY	$84.2 - $98.62 $394,898 - $462,527	4,690 New	4,690 $417,000
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $23,491 - $27,514	279 Added 6.33%	4,690 $417,000
Q4 2018 Oct 03, 2024	BUY	$80.14 - $106.07 $353,497 - $467,874	4,411 New	4,411 $376,000
Q4 2018 Feb 06, 2019	SELL	$80.14 - $106.07 $20,756 - $27,472	-259 Reduced 5.55%	4,411 $376,000
Q3 2018 Oct 04, 2024	BUY	$93.92 - $105.72 $438,606 - $493,712	4,670 New	4,670 $453,000
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $446,589 - $502,698	-4,755 Reduced 50.45%	4,670 $453,000
Q2 2018 Oct 04, 2024	BUY	$76.01 - $99.03 $716,394 - $933,357	9,425 New	9,425 $888,000
Q2 2018 Aug 10, 2018	SELL	$76.01 - $99.03 $103,297 - $134,581	-1,359 Reduced 12.6%	9,425 $888,000
Q1 2018 Oct 04, 2024	BUY	$77.67 - $92.63 $290,408 - $346,343	3,739 Added 53.07%	10,784 $874,000
Q1 2018 May 01, 2018	BUY	$77.67 - $92.63 $290,408 - $346,343	3,739 Added 53.07%	10,784 $874,000
Q4 2017 Oct 04, 2024	BUY	$80.76 - $95.13 $568,954 - $670,190	7,045 New	7,045 $628,000
Q4 2017 Jan 26, 2018	BUY	$80.76 - $95.13 $337,173 - $397,167	4,175 Added 145.47%	7,045 $628,000
Q3 2017 Nov 13, 2017	SELL	$80.6 - $94.95 $104,135 - $122,675	-1,292 Reduced 31.04%	2,870 $267,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,162	4,162 $378,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.44 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.22 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.2 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$881 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$666 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account